International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Learn more about:
Related Clinical Trial
A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)
Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
The Plasma Large-Volume Exchange RCT
Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients – ECULISHU
Rituximab in Patients With Relapsed or Refractory TTP-HUS
Usefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in Pregnancy
Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
Study of ‘Vascular Competence’ Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects
Outcame of Cases With Hemolytic Uremic Syndrome Attending Assiut University Child Hospital
Erythropoietin in Hemolytic Uremic Syndrome
Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4